A leading U.S. OB-GYN group, the American College of Obstetricians and Gynecologists (ACOG), issues new guidance supporting hormone therapy for many women experiencing common menopause symptoms such as hot flashes. The updated recommendations emphasize individualized care and weigh symptom relief against potential risks.
Both outlets report that ACOG says, for many people, the benefits of hormone therapy outweigh the harms. The guidance is directed at women who have bothersome symptoms related to menopause and seeks to clarify when hormone treatment is appropriate, while still recognizing that risk varies by individual health history.
While the stories focus on the overall direction of the new recommendations, they align on the core message: hormone therapy remains a central option for managing prevalent menopause symptoms under updated clinical guidance. The reports do not provide detailed numbers or subgroup thresholds within their summaries, instead highlighting ACOG’s stance and the intent to support broader access to effective symptom management for eligible patients.
